Corvex Reports Q3 2026 Revenue of $5.0 Million and $17.5 Million Net Loss

Corvex reported third-quarter 2026 revenue of $5.0 million and a net loss of $17.5 million, or $0.60 per share. Adjusted EBITDA was a loss of $3.2 million. The quarter was Corvex’s first full reporting period following the transfer of its legacy healthcare assets on June 30, 2026, making prior-year…